Response to chemotherapy according to RRM1 expression.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
*Based on Fisher’s exact test. In patients receiving gemcitabine-based therapy, the DCR of RRM1-negative patients was higher than RRM1-positive patients (P = 0.041). #Based on Fisher’s exact test. In patients with RRM1-positive tumors, the DCRs for docetaxel and vinorelbine were higher than for gemcitabine-based therapy (P = 0.047 and P = 0.047, respectively).
创建时间：
2014-03-19
